# Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

Study · id `cardio:ct-nct02594501` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02594501](<https://clinicaltrials.gov/study/NCT02594501>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02594501

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 996 participants.

## Technical summary

Registry record NCT02594501. Randomized; no masking; primary purpose treatment. Start 2016-02-05 (registry gives no type); primary completion 2021-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 996 participants (enrolled count; ClinicalTrials.gov record NCT02594501, source copy `cardio:ctgov-nct02594501-2020-10-26`, retrieved 2026-10-31)
- Start date: 2016-02-05 (registry gives no type) (ClinicalTrials.gov record NCT02594501, source copy `cardio:ctgov-nct02594501-2020-10-26`, retrieved 2026-10-31)
- Primary completion: 2021-05 (anticipated) (ClinicalTrials.gov record NCT02594501, source copy `cardio:ctgov-nct02594501-2020-10-26`, retrieved 2026-10-31)
- Completion: 2021-11 (anticipated) (ClinicalTrials.gov record NCT02594501, source copy `cardio:ctgov-nct02594501-2020-10-26`, retrieved 2026-10-31)
- Countries: United States; Belgium; Denmark; France; Germany; Italy; Latvia; Switzerland (ClinicalTrials.gov record NCT02594501, source copy `cardio:ctgov-nct02594501-2020-10-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02594501-2020-10-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
- Acronym: COBRA-REDUCE
- Condition: Angina, Stable
- Condition: Angina, Unstable
- Condition: Anticoagulants
- Intervention (Device): COBRA PzF
- Intervention (Device): Drug Eluting Stent
- Lead sponsor: CeloNova BioSciences, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial (`cardio:pubmed-39405373`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long term follow up of patients treated with a polymer coated non drug-eluting stent in the COBRA-REDUCE trial (`cardio:pubmed-40050141`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6796e3a73f65ebd89ceb9934807fdeee86213ebbb1f8a6949a3ebcb4f44ef277
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
